0001209191-23-058578.txt : 20231214
0001209191-23-058578.hdr.sgml : 20231214
20231214081104
ACCESSION NUMBER: 0001209191-23-058578
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231213
FILED AS OF DATE: 20231214
DATE AS OF CHANGE: 20231214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Angotti Vincent J.
CENTRAL INDEX KEY: 0001700225
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 231485652
MAIL ADDRESS:
STREET 1: C/O ACELRX PHARMACEUTICALS, INC.
STREET 2: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1850 GATEWAY DRIVE
STREET 2: SUITE 175
CITY: SAN MATEO
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 1850 GATEWAY DRIVE
STREET 2: SUITE 175
CITY: SAN MATEO
STATE: CA
ZIP: 94404
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-13
0
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001700225
Angotti Vincent J.
C/O ACELRX PHARMACEUTICALS, INC.
1850 GATEWAY DRIVE, SUITE 175
SAN MATEO
CA
94404
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-12-13
4
P
0
10000
0.7268
A
101805
D
The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.7198 to $0.73 on December 13, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.
/s/ Martha Adler, Attorney-In-Fact
2023-12-14